Generate Biomedicines Inc's (NASDAQ:GENB) Lock-Up Period To End on August 26th
Generate Biomedicines Inc. (NASDAQ:GENB) will have its lock-up period expire on August 26th, allowing insiders and major shareholders to sell shares from its initial public offering. The company issued 25 million shares at $16.00 in February, totaling $400 million. Analyst sentiment is a "Moderate …